{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-249225","form_type":"8-K","ticker":"CORT","cik":"0001088856","company_name":"CORCEPT THERAPEUTICS INC","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.947255+00:00","generated_at":"2026-06-23T07:54:36.261565+00:00","sec_items":["1.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Corcept extends exclusive specialty pharmacy agreement for Korlym with Optime to March 2024","bullets":["Amendment extends Optime's exclusive dispensing services for Korlym to March 31, 2024.","No financial terms disclosed; original agreement from August 2017.","Optime remains sole specialty pharmacy for Korlym in the United States."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-249225","json":"https://secwatch.observer/filing/0001193125-22-249225.json","markdown":"https://secwatch.observer/filing/0001193125-22-249225.md","text":"https://secwatch.observer/filing/0001193125-22-249225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/0001193125-22-249225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/d325698d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:54:36.261565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}